Domestic pharmaceutical companies win on the formulation patent trial over Cialis
In regards to ‘Cialis,’ the impotency treatment which will be expired in its substance patent on the coming September, the first trial decision has been made against patent challenges of domestic pharmaceutical companies.
As Cialis, a blockbuster pharmaceutical product recoding approximately KRW...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
